ProACT Post-Approval Study
NCT03767595
This study is recruiting at 14 US sites in 10 states, according to its ClinicalTrials.gov record last updated .
Summary
The ProACT Post Approval Study is a 5-year prospective, open-label, multi-center study designed to evaluate the long-term incidence of urethral stricture and device erosion after ProACT implantation. In addition, the study will evaluate whether treatment with ProACT affects clinical outcomes after subsequent SUI therapies.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Stress Urinary Incontinence
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 50 years and older
- Sex
- Male
- Healthy volunteers
- Accepted
- Sponsor
- Uromedica
- Last updated on ClinicalTrials.gov
- October 6, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 2
- University of Southern California · Los Angeles, CA
- Sutter Health · Santa Barbara, CA
Colorado · 1
- University of Colorado · Denver, CO
Florida · 2
- University of Florida · Gainesville, FL
- Urological Research Network Corp · Hialeah, FL
Georgia · 1
- Emory University · Atlanta, GA
Kansas · 1
- University of Kansas Medical Center · Kansas City, KS
Michigan · 1
- University of Michigan · Ann Arbor, MI
Minnesota · 1
- CentraCare- St. Cloud · Saint Cloud, MN
Nebraska · 1
- CHI Health Research · Omaha, NE
Pennsylvania · 2
- Lehigh Valley Health Network · Allentown, PA
- Allegheny Health Network · Pittsburgh, PA
Texas · 2
- Urology Partners of North Texas Research Institute · Arlington, TX
- DHR Health Institute for Research and Development · McAllen, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.